Income statement
USD
Annual
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 339K | 173K | 0 | 0 | 0 |
| Gross Profit | 142K | 65K | 0 | 0 | 0 |
| Operating Income | -188K | -319K | -77K | -21K | -7K |
| EBITDA | -167K | -312K | 0 | 0 | 193K |
| Net Income | -412K | -2M | -10M | -89K | -92K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.15
+30.00% today
Window Change
-64.23%
Window
Jun 26, 2025 → May 6, 2026
Coverage: 166 bars · Jun 26, 2025 → May 6, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Standard Dental Labs Inc. (TUTH) is a Healthcare stock with a market cap of $4.85M and listed on OTC. The stock last traded around $0.15 and down 64.2% across the available one-year price window (Jun 26, 2025 → May 6, 2026). Baseline metrics include revenue growth of +95.9%, EPS growth of +75.7%, a dividend yield of 0.0%. What stands out right now is revenue +95.9%, EPS +75.7%, free cash flow -124.5% with operating margin -55.4% and ROIC 1752.9%. Valuation sits in the middle of the pack at price/sales 5.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TUTH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TUTH
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TUTH Max Drawdown
-94.03%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TUTH and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$91.8K
-3.1% YoY
Free Cash Flow
-$84.5K
-3.0% YoY
Revenue Growth
+95.9%
EPS Growth
+75.7%
Gross Margin
41.7%
Net Margin
-121.4%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 339K | 173K | 0 | 0 | 0 |
| Gross Profit | 142K | 65K | 0 | 0 | 0 |
| Operating Income | -188K | -319K | -77K | -21K | -7K |
| EBITDA | -167K | -312K | 0 | 0 | 193K |
| Net Income | -412K | -2M | -10M | -89K | -92K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2K | 13K | 0 | 0 | 0 |
| Total Assets | 155K | 188K | 0 | 0 | 0 |
| Total Liabilities | 2M | 2M | 133K | 1M | 1M |
| Shareholder Equity | -2M | -2M | -133K | -1M | -1M |
| Total Debt | 2M | 1M | 26K | 1M | 1M |
| Net Debt | 2M | 1M | 26K | 1M | 1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
85K
-3.0% YoY
Capital Expenditures
0
Free Cash Flow
85K
-3.0% YoY
Key ratios
Gross Margin
41.7%
Operating Margin
-55.4%
Net Margin
-121.4%
ROE
26.5%
Debt / Equity
-0.99x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.